The dominant mode of reproduction in eucaryotes is sexual. This has been described as a paradox given that sex is much more costly than reproducing asexually, such as by parthenogenesis. In the Crustacea, parthenogenesis is commonly found in the Ostracoda and Branchiopoda (Artemia and Cladocera), and studies of these species have made important contributions to understanding the ecological and evolutionary relationship between sexual and asexual reproduction. With respect to parthenogenesis, researchers have explored its taxonomic distribution and phylogeny, origin and mode, ecological genetics, and genomic signatures. Parthenogenetic Crustacea include both diploid and polyploid clones that have originated multiple times from related sexual species but appear to have a relatively limited evolutionary lifespan. Darwinulid ostracods may be one exception, with no known sexual forms and possibly an example of ancient asexuality, although this is controversial. Most parthenogenetic crustacean groups appear to have a wider geographic distribution than related sexual species and are often found in marginal habitats associated with higher latitudes and altitudes. Such patterns of geographic parthenogenesis have yet to be fully explained, but could possibly be due to colonization and adaptation advantages of asexuality; further studies are required to eliminate polyploidy alone as an explanation. There are many examples of parthenogenetic ostracods, cladocerans, and Artemia showing high levels of genetic diversity likely due to recent multiple origins from related sexual species. Phylogenetic analyses support this explanation and for Artemia and Daphnia, cases have been documented for rare functional males produced by parthenogenetic females that can mate with sexual females as a mechanism for generating new clonal lineages. The diversity of asexual species, combined with prior ecological and genetic information, suggests that crustaceans will continue as important models for understanding parthenogenesis, particularly with the application of new genomic tools.